alexa Clinical Next Generation Sequencing Of Tumors: Potential, Advantages And Future Prospects
ISSN: 2161-0681

Journal of Clinical & Experimental Pathology
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Share This Page

Additional Info

Loading
Loading Please wait..
 

3rd International Conference and Exhibition on Pathology
April 14-15, 2014 Hilton San Antonio Airport, TX, USA

R. Rajesh Singh
ScientificTracks Abstracts: J Clin Exp Pathol
DOI: 10.4172/2161-0681.S1.012
Abstract
Next Generation Sequencing (NGS) represents a revolutionary high throughput sequencing technology, which enables massive parallel sequencing of tens and hundreds of genes utilizing a single investment of low quantity of DNA. This technology represents a major advantage over the single gene and low throughput sequencing platforms, which when needed to screen for multiple markers are labor intensive, have high DNA requirements and expensive. As the number of markers to be routinely screened in cancer diagnostics is increasing, NGS is being rapidly adapted for routine mutational screening of both solid tumors and hematological malignancies in diagnostic labs. However, application of these technologies in diagnostic arena also presents several challenges, which includes rigorous validation of these relatively new technologies to assess their suitability for routine diagnostics, evolving guidelines for validation and application and need for special bioinformatics and clinical reporting infrastructure. Rapid changes and improvements of the wet bench and analytical technology also warrant frequent revalidations before induction for clinical use. The need for changes in billing and reimbursement format to accommodate NGS into the model of single-gene tests and reporting of incidental findings also raise financial and ethical challenges, respectively.
Biography
Rajesh Singh has a Ph.D. in Biochemistry from The University of Mysore, India and Postdoctoral research experience from University of Texas, MD Anderson Cancer Center. He has extensive experience in cancer biology focusing on the deregulated oncogenic and tumor suppressor pathways in the origin and maintenance of solid tumors and hematological malignancies. He is an Assistant Professor in the molecular diagnostics laboratory at MD Anderson, where he supervises the development team involved in design and validation of the NGS assays for routine mutational screening of tumors. He has published more than 36 papers and 3 review articles in reputed journals.
image PDF   |   image HTML
 
Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri, Food, Aqua and Veterinary Science Journals

Dr. Krish

[email protected]

1-702-714-7001 Extn: 9040

Clinical and Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemical Engineering and Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001 Extn: 9040

Earth & Environmental Sciences

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

General Science and Health care Journals

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics and Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001 Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Informatics Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Material Sciences Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Mathematics and Physics Journals

Jim Willison

[email protected]

1-702-714-7001 Extn: 9042

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001 Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

John Behannon

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001 Extn: 9042

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords